Trinity Biotech plc

NASDAQ:TRIB

Medical - Diagnostics & Research

Healthcare
$5.83 -5.73%

-$0.51 today

Market cap
$117.96M
Beta
1.00
P/E (TTM)
-0.1
EPS (TTM)
-$60.27
52W Low $8.00High $103.20

Volume 0.00M

Average 1.34M

TRIB Short-term Debt

Borrowings and the current portion of long-term debt due within one year.

Trinity Biotech plcNASDAQ: TRIB

Short-term Debt · Q4 FY2025 · quarter ended Dec 2025

Short-term debt rises 52668.1% from a year ago

Short-term debt stood at $110.81M at the end of Q4 FY2025, up 52668.1% from a year earlier and up 4631.6% from the prior quarter. Over 3 fiscal years it compounded at +708.1% a year.

Context

  • Short-term debt amounted to 105.4% of total assets at the end of Q4 FY2025, up 105.2 pp from a year earlier.
  • Short-term debt increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether short-term debt keeps rising in the next quarterly balance sheet after a +52668.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterDec 2025
$110.81M+4631.6% QoQ
Last fiscal yearDec 2025
$110.81M+52668.1% YoY
Year agoDec 2024
$210K+52668.1% since
Short-term Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+52668.1%——
1 year+52668.1%——
3-year CAGR+708.1%——
5-year CAGR——
10-year CAGR——

Short-term Debt history

USD · from the balance sheet

Latest · FY2025
110.81M USD
Year-over-year change
+52668.1%
4-year CAGR
+7.4%

Short-term Debt vs competitors

How TRIB compares with its peers on the latest reported figures

No competitor Short-term Debt figures are available to compare.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents25.91M6.58M3.69M5.17M5.14M
Short-term Investments00000
Net Receivables15.71M15.65M13.38M14.6M10.28M
Inventory29.12M22.5M19.93M19.37M18.83M
Other Current Assets01K000
Total Current Assets72.69M46.67M39.04M41.12M35.9M
Property, Plant & Equipment (Net)5.92M5.68M1.89M4.62M5.3M
Goodwill12.54M12.54M013.84M13.97M
Intangible Assets23.44M22.73M16.27M37.5M43.02M
Long-term Investments151K212K214K2.46M3.02M
Tax Assets4.1M4.22M1.98M3.55M3.92M
Other Non-current Assets56K55K43K194K28K
Total Non-current Assets46.21M45.44M20.39M62.17M69.26M
Total Assets118.9M92.1M59.44M103.29M105.17M
Account Payables6.76M6.21M3.89M6.83M11.48M
Short-term Debt83.31M210K210K210K110.81M
Tax Payables420K28K279K1.02M0
Deferred Revenue141K114K50K197K187K
Other Current Liabilities249K153K160K2.57M18.38M
Total Current Liabilities100.49M17.34M15.04M32.1M141.21M
Long-term Debt058.05M54.65M87.79M16.33M
Deferred Tax Liabilities4.86M5.06M2.3M4.56M4.67M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities4.86M1.57M526K3.55M4.1M
Total Non-current Liabilities18.72M76.94M68.35M106.38M35.94M
Total Liabilities119.21M94.28M83.38M138.47M177.15M
Common Stock1.21M1.96M1.97M4.19M40K
Retained Earnings12.56M(26.7M)(48.64M)(79.12M)(116.17M)
Accumulated OCI(5.36M)(5.69M)1.03M(5.44M)5.27M
Other Stockholders Equity06.71M06.71M0
Minority Interest00000
Total Equity(319K)(2.18M)(23.95M)(35.18M)(71.98M)
Total Debt99.16M72.2M67.43M100.76M137.98M
Net Debt73.25M51.68M63.74M95.6M132.85M

Trinity Biotech plc

NASDAQ:TRIB

Intrinsic Alpha fair value

Locked

Current Price

$5.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.